NAPRT and cancer: Secondly, it can also be combined with some adjuvant drugs to reduce cytotoxicity: Zhao, Genshi et al. reported that NAMPTi, named LSN3154567, inhibits the proliferation of many different cancer cell lines, especially NAPRT1-deficient cancer cell lines.